SPPI Spectrum Pharmaceuticals, Inc. Stock Quote

SPPI [NASD]

Index	-	P/E	-	EPS (ttm)	-1.25	Insider Own	1.40%	Shs Outstand	145.37M	Perf Week	16.49%
Market Cap	722.50M	Forward P/E	-	EPS next Y	-0.47	Insider Trans	-19.44%	Shs Float	137.35M	Perf Month	42.17%
Income	-166.30M	PEG	-	EPS next Q	-0.26	Inst Own	64.60%	Short Float	11.38%	Perf Quarter	20.60%
Sales	-	P/S	-	EPS this Y	-12.50%	Inst Trans	1.72%	Short Ratio	5.55	Perf Half Y	-5.12%
Book/sh	0.84	P/B	5.30	EPS next Y	47.70%	ROA	-77.20%	Target Price	-	Perf Year	56.69%
Cash/sh	1.00	P/C	4.44	EPS next 5Y	-	ROE	-112.30%	52W Range	2.68 - 5.24	Perf YTD	30.50%
Dividend	-	P/FCF	-	EPS past 5Y	-11.20%	ROI	-	52W High	-15.08%	Beta	2.19
Dividend %	-	Quick Ratio	3.60	Sales past 5Y	-	Gross Margin	-	52W Low	66.05%	ATR	0.20
Employees	176	Current Ratio	3.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	81.99	Volatility	6.40% 5.71%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	32.50%	Profit Margin	-	Rel Volume	0.60	Prev Close	4.39
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 13 AMC	Payout	-	Avg Volume	2.81M	Price	4.45
Recom	2.20	SMA20	22.77%	SMA50	35.14%	SMA200	18.18%	Volume	1,679,508	Change	1.37%

Sep-17-20

Initiated

JMP Securities

Mkt Outperform

$12

Dec-26-19

Downgrade

Guggenheim

Buy → Neutral

Dec-26-19

Downgrade

Cantor Fitzgerald

Overweight → Neutral

$17 → $4

Nov-27-19

Resumed

B. Riley FBR

Buy

$18

Jul-11-19

Initiated

B. Riley FBR

Buy

$18

Mar-15-19

Resumed

Jefferies

Buy

$21

Nov-12-18

Reiterated

B. Riley FBR

Buy

$35 → $29

Dec-18-17

Initiated

B. Riley FBR, Inc.

Buy

$26

Oct-24-17

Initiated

Guggenheim

Buy

$32

Oct-19-17

Reiterated

H.C. Wainwright

Buy

$20 → $29

Oct-04-17

Reiterated

H.C. Wainwright

Buy

$14 → $20

Aug-16-17

Resumed

H.C. Wainwright

Buy

$14

Feb-10-17

Resumed

Jefferies

Buy

Nov-05-15

Reiterated

RBC Capital Mkts

Outperform

$13 → $12

Aug-07-15

Reiterated

RBC Capital Mkts

Outperform

$12 → $13

Apr-02-15

Initiated

FBR Capital

Outperform

Feb-23-15

Downgrade

ROTH Capital

Buy → Neutral

$15 → $7

Jul-15-14

Upgrade

R. F. Lafferty

Sell → Neutral

$7.50

Oct-07-13

Initiated

HC Wainwright

Buy

$15

May-29-13

Initiated

Burrill Institutional Research

Mkt Outperform

$12

Jun-04-21 09:00AM	Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting Business Wire
Jun-01-21 07:00AM	Spectrum Pharmaceuticals Announces That the ROLONTIS® (eflapegrastim) Pre-Approval Inspection Has Been Initiated Business Wire +6.96%
04:50AM	Will Spectrum Pharmaceuticals (NASDAQ:SPPI) Spend Its Cash Wisely? Simply Wall St.
May-28-21 07:00AM	Spectrum Pharmaceuticals to Present Data for Poziotinib in Patients with Brain Metastases at the Upcoming 2021 ASCO Annual Meeting Business Wire
May-27-21 07:00AM	Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences in June Business Wire
May-13-21 08:30PM	Spectrum Pharmaceuticals Inc (SPPI) Q1 2021 Earnings Call Transcript Motley Fool
04:00PM	Spectrum Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Update Business Wire
02:30PM	Spectrum Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
May-06-21 07:00AM	Spectrum Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Corporate Update Business Wire
Apr-10-21 08:30AM	Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021 Business Wire
Apr-05-21 07:00AM	Spectrum Pharmaceuticals Presentations at the Upcoming AACR Virtual Meeting 2021 to Include Updated Poziotinib Twice Daily Dosing Data Business Wire
Mar-30-21 08:00PM	Spectrum Pharmaceuticals Inc (SPPI) Q4 2020 Earnings Call Transcript Motley Fool
04:00PM	Spectrum Pharmaceuticals Reports Fourth Quarter 2020 and Full Year 2020 Financial Results and Pipeline Update Business Wire
Mar-26-21 04:00PM	Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update Business Wire
Mar-16-21 07:00AM	Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection Business Wire
Mar-12-21 09:33AM	Spectrum's (SPPI) NSCLC Drug Gets FDA's Fast Track Designation Zacks -5.63%
Mar-11-21 08:19AM	The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena Benzinga +18.84%
07:00AM	FDA Grants Fast Track Designation to Spectrum Pharmaceuticals Poziotinib Business Wire
06:06AM	Spectrum Pharma Climbs as FDA to Fast-Track Cancer Drug Review TheStreet.com
Mar-03-21 03:00AM	How Much Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Do Institutions Own? Simply Wall St. -6.55%
Mar-02-21 11:45AM	Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021 Business Wire
Feb-26-21 07:00AM	Spectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer Conference Business Wire
Feb-23-21 07:00AM	Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021 Business Wire
Feb-04-21 07:00AM	Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day Business Wire
Jan-22-21 07:00AM	Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer Business Wire
Jan-05-21 07:00AM	Spectrum Pharmaceuticals to Participate in Three Upcoming Investor Conferences in January Business Wire
Dec-23-20 08:29AM	The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga -9.06%
Dec-22-20 04:05PM	Spectrum Provides Poziotinib Update after Successful Pre-NDA Meeting with the FDA Business Wire
Dec-17-20 08:00AM	BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors GlobeNewswire
Dec-14-20 07:07AM	Is SPPI A Good Stock To Buy Now? Insider Monkey +8.90%
07:00AM	Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors Business Wire
Dec-04-20 07:00AM	Spectrum Pharmaceuticals Announces Three Poster Presentations at Upcoming San Antonio Breast Cancer Symposium Business Wire
Dec-03-20 02:45AM	Will Spectrum Pharmaceuticals (NASDAQ:SPPI) Spend Its Cash Wisely? Simply Wall St.
Nov-16-20 05:34PM	FDA delays decision on Bristol Myers cancer therapy due to COVID-19 travel curbs Reuters
Nov-09-20 07:00AM	Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in November Business Wire +7.43%
Nov-04-20 09:32PM	Spectrum Pharmaceuticals Inc (SPPI) Q3 2020 Earnings Call Transcript Motley Fool
05:35PM	Spectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:25PM	Recap: Spectrum Pharmaceuticals Q3 Earnings Benzinga
04:00PM	Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update Business Wire
02:30PM	Spectrum Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Oct-28-20 07:00AM	Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update Business Wire
Oct-26-20 07:23AM	FDA delays approval of Spectrum Pharma's drug due to COVID-19 Reuters
07:00AM	Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim) Business Wire
Sep-21-20 09:04AM	Spectrum Pharmaceuticals (SPPI) Jumps: Stock Rises 7% Zacks
Sep-18-20 07:00AM	Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial Business Wire +6.99%
Sep-17-20 09:41AM	Benzinga's Top Upgrades, Downgrades For September 17, 2020 Benzinga +9.57%
Sep-16-20 08:42AM	Implied Volatility Surging for Spectrum (SPPI) Stock Options Zacks
Sep-14-20 07:00AM	Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020 Business Wire +7.89%
Sep-08-20 07:00AM	Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September Business Wire
Sep-04-20 02:21PM	What You Need To Know About Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Investor Composition Simply Wall St.
Aug-10-20 08:30PM	Spectrum Pharmaceuticals Inc (SPPI) Q2 2020 Earnings Call Transcript Motley Fool
05:35PM	Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:00PM	Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update Business Wire
Aug-05-20 04:00PM	Spectrum Pharmaceuticals Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire +6.19%
Aug-03-20 07:00AM	Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update Business Wire +5.69%
Jul-30-20 12:59PM	Why Spectrum Pharmaceuticals Is Plunging Today Motley Fool -20.10%
07:00AM	Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock Business Wire
Jul-29-20 04:27PM	Spectrum Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire +6.30%
Jul-28-20 12:00PM	Why Spectrum Pharmaceuticals Stock Is on Fire Today Motley Fool +12.65%
08:44AM	Spectrum Pharma Spikes on Positive Lung Cancer Treatment Data TheStreet.com
03:32AM	Spectrum Pops 71% In After-Hours On Positive Data For Lung Cancer Treatment SmarterAnalyst
Jul-27-20 04:00PM	Spectrum Pharmaceuticals Announces Positive Topline Results in HER2 Exon20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Trial Business Wire
Jul-16-20 09:00AM	Tarsus Pharmaceuticals Announces Appointment of New COO and CFO PR Newswire
Jul-02-20 08:51AM	Spectrum Pharma (SPPI) Soars: Stock Adds 9.2% in Session Zacks -7.05%
Jun-25-20 11:23AM	3 Biotech Stocks Under $5 With 100%-Plus Upside Potential TipRanks
Jun-22-20 09:00AM	Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS® (eflapegrastim) at AACR Virtual Annual Meeting II Business Wire
Jun-21-20 10:39PM	Hedge Funds Souring On Spectrum Pharmaceuticals, Inc. (SPPI) Insider Monkey
Jun-17-20 07:58PM	Edited Transcript of SPPI earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-16-20 07:00AM	Spectrum Pharmaceuticals to Present Preclinical ROLONTIS® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II Business Wire
Jun-06-20 11:31AM	Why Is Spectrum Pharma (SPPI) Up 6.6% Since Last Earnings Report? Zacks
Jun-05-20 03:37AM	Edited Transcript of SPPI earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Jun-03-20 04:00PM	Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development Business Wire
May-27-20 07:00AM	Spectrum Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference 2020 Business Wire
May-11-20 10:41AM	Spectrum Pharma (SPPI) Incurs Wider-Than-Expected Q1 Loss Zacks +11.62%
May-08-20 11:00PM	Spectrum Pharmaceuticals Inc (SPPI) Q1 2020 Earnings Call Transcript Motley Fool -6.23%
May-07-20 04:00PM	Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update Business Wire
May-01-20 07:00AM	Spectrum Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Corporate Update Business Wire -7.59%
Apr-30-20 07:00AM	Spectrum Pharmaceuticals Initiates Same Day Dosing Clinical Trial for ROLONTIS® (eflapegrastim) Business Wire
Apr-28-20 07:00AM	Spectrum Pharmaceuticals Provides Strategy Update for Poziotinib Development Program Business Wire
Apr-23-20 07:00AM	Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors Business Wire
Apr-21-20 07:00AM	Spectrum Pharmaceuticals to Present Data from Phase 2 Clinical Trial for Poziotinib at American Association for Cancer Research Virtual Annual Meeting 2020 Business Wire
Apr-14-20 10:37AM	Will Spectrum Pharmaceuticals (NASDAQ:SPPI) Spend Its Cash Wisely? Simply Wall St.
Mar-28-20 11:30AM	Spectrum Pharma (SPPI) Down 4.6% Since Last Earnings Report: Can It Rebound? Zacks
Mar-17-20 11:12AM	Top Small Cap Stocks for April 2020 Investopedia
07:00AM	Spectrum Pharmaceuticals Cancelled Participation in Upcoming Medical Conference Due to Coronavirus Pandemic Business Wire
Mar-11-20 07:00AM	Spectrum Pharmaceuticals to Present Data from Phase 2 Clinical Trial for Poziotinib at Upcoming Medical Conference Business Wire -8.08%
Mar-03-20 07:00AM	Spectrum Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2020 Business Wire
Mar-02-20 08:00AM	The Rosen Law Firm P.A. and Bronstein Gewirtz & Grossman, LLC Announce Proposed Class Action Settlement on Behalf of Purchasers of Securities of Spectrum Pharmaceuticals, Inc. -- SPPI GlobeNewswire
Feb-28-20 08:46AM	Spectrum Pharma (SPPI) Incurs Wider-Than-Expected Q4 Loss Zacks +19.17%
Feb-27-20 04:00PM	Spectrum Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Pipeline Update Business Wire -8.05%
Feb-20-20 09:27AM	What Awaits Spectrum Pharmaceuticals (SPPI) in Q4 Earnings? Zacks +6.62%
07:00AM	Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call Business Wire
Feb-06-20 07:00AM	Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum Oncology Day on February 13th Business Wire
Jan-17-20 05:50PM	Spectrum Pharmaceuticals (SPPI) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-15-20 01:39PM	Such Is Life: How Spectrum Pharmaceuticals (NASDAQ:SPPI) Shareholders Saw Their Shares Drop 68% Simply Wall St.
Dec-27-19 02:50PM	Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone Benzinga
08:05AM	Spectrum Pharmaceuticals is Oversold: Can It Recover? Zacks
07:59AM	The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping Benzinga
06:56AM	Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goals MarketWatch
Dec-26-19 03:57PM	PreMarket Prep Recap: Qiagen Pulls The Rug Out From Investors Banking On A Deal, Bad Data Equals Bad Price Action For Spectrum Pharmaceuticals Benzinga -60.00%

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Henderson, Nevada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Riga Thomas J	EVP, COO & CCO	May 14	Sale	3.07	2,250	6,908	406,879	May 14 07:31 PM
McGahan Keith M	Chief Legal Officer	May 14	Sale	3.07	525	1,612	311,934	May 14 07:27 PM
McGahan Keith M	Chief Legal Officer	May 13	Sale	3.09	434	1,339	312,459	May 14 07:27 PM
Riga Thomas J	EVP, COO & CCO	May 13	Sale	3.09	3,402	10,499	409,129	May 14 07:31 PM
LEBEL FRANCOIS	Chief Medical Officer	Apr 06	Sale	3.24	1,025	3,321	350,867	Apr 06 05:50 PM
LEBEL FRANCOIS	Chief Medical Officer	Apr 05	Sale	3.31	1,125	3,726	351,892	Apr 06 05:50 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Mar 16	Sale	3.69	16,318	60,213	400,451	Mar 17 06:08 PM
LEBEL FRANCOIS	Chief Medical Officer	Mar 16	Sale	3.69	18,828	69,475	353,017	Mar 17 06:08 PM
McGahan Keith M	Chief Legal Officer	Mar 16	Sale	3.69	16,318	60,213	316,832	Mar 17 06:51 PM
Riga Thomas J	EVP, COO & CCO	Mar 16	Sale	3.69	18,828	69,475	412,531	Mar 17 06:52 PM
Turgeon Joseph W.	CEO & President	Mar 16	Sale	3.69	28,243	104,217	565,028	Mar 17 06:53 PM
Turgeon Joseph W.	CEO & President	Mar 15	Sale	3.62	40,091	145,330	593,271	Mar 17 06:53 PM
Riga Thomas J	EVP, COO & CCO	Mar 15	Sale	3.62	23,291	84,430	431,359	Mar 17 06:52 PM
McGahan Keith M	Chief Legal Officer	Mar 15	Sale	3.62	14,362	52,062	333,150	Mar 17 06:51 PM
LEBEL FRANCOIS	Chief Medical Officer	Mar 15	Sale	3.62	22,631	82,037	371,845	Mar 17 06:08 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Mar 15	Sale	3.62	20,365	73,823	416,769	Mar 17 06:08 PM
Turgeon Joseph W.	CEO & President	Feb 22	Sale	3.73	7,500	27,975	633,362	Feb 23 05:00 PM
Riga Thomas J	EVP, COO & CCO	Feb 22	Sale	3.73	5,000	18,650	454,650	Feb 23 04:19 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Feb 22	Sale	3.73	4,000	14,920	437,134	Feb 23 04:27 PM
McGahan Keith M	Chief Legal Officer	Feb 22	Sale	3.73	4,000	14,920	347,512	Feb 23 04:33 PM
McGahan Keith M	Chief Legal Officer	Feb 19	Sale	3.64	3,295	11,984	351,512	Feb 23 04:33 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Feb 19	Sale	3.64	4,672	16,992	441,134	Feb 23 04:27 PM
Riga Thomas J	EVP, COO & CCO	Feb 19	Sale	3.64	5,018	18,250	459,650	Feb 23 04:19 PM
Turgeon Joseph W.	CEO & President	Feb 19	Sale	3.64	7,257	26,394	640,862	Feb 23 05:00 PM
McGahan Keith M	Chief Legal Officer	Feb 10	Sale	3.93	2,500	9,825	244,498	Feb 10 05:29 PM
McGahan Keith M	Chief Legal Officer	Feb 09	Sale	3.93	1,977	7,770	246,998	Feb 10 05:29 PM
Turgeon Joseph W.	CEO & President	Jan 20	Sale	4.31	3,889	16,762	370,029	Jan 20 08:33 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Jan 20	Sale	4.31	1,944	8,379	330,608	Jan 20 08:33 PM
Riga Thomas J	EVP, COO & CCO	Jan 20	Sale	4.31	10,000	43,100	330,258	Jan 20 08:34 PM
Riga Thomas J	EVP, COO & CCO	Jan 19	Sale	3.97	76,283	302,894	340,258	Jan 20 08:34 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Jan 19	Sale	3.81	2,582	9,832	332,552	Jan 20 08:33 PM
Turgeon Joseph W.	CEO & President	Jan 19	Sale	3.81	3,844	14,638	373,918	Jan 20 08:33 PM
Turgeon Joseph W.	CEO & President	Dec 16	Sale	4.70	150,899	709,225	377,762	Dec 18 07:18 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Dec 14	Sale	5.00	25,696	128,480	335,134	Dec 16 05:16 PM
Turgeon Joseph W.	CEO & President	Nov 18	Sale	4.13	162,473	671,013	528,661	Nov 20 05:10 PM
LEBEL FRANCOIS	Chief Medical Officer	Nov 09	Sale	3.56	5,000	17,800	306,424	Nov 09 08:08 PM
LEBEL FRANCOIS	Chief Medical Officer	Nov 06	Sale	3.50	7,025	24,609	301,424	Nov 09 08:08 PM
McGahan Keith M	Chief Legal Officer	Aug 12	Sale	3.71	250	928	248,769	Aug 12 05:44 PM
McGahan Keith M	Chief Legal Officer	Aug 11	Sale	4.03	294	1,183	249,019	Aug 12 05:44 PM
McGahan Keith M	Chief Legal Officer	Jul 09	Sale	3.36	13,881	46,640	249,313	Jul 09 06:24 PM
McGahan Keith M	Chief Legal Officer	Jun 24	Sale	3.21	15,773	50,631	262,986	Jun 25 05:01 PM
LEBEL FRANCOIS	Chief Medical Officer	Jun 23	Sale	3.35	4,167	13,959	292,729	Jun 23 05:23 PM
LEBEL FRANCOIS	Chief Medical Officer	Jun 22	Sale	3.16	5,474	17,320	296,896	Jun 23 05:23 PM
Ashton William	Director	Jun 22	Sale	3.25	5,000	16,250	41,666	Jun 23 04:30 PM
McGahan Keith M	Chief Legal Officer	Jun 22	Sale	3.25	3,000	9,750	278,759	Jun 23 04:11 PM
McGahan Keith M	Chief Legal Officer	Jun 19	Sale	3.13	3,459	10,820	281,759	Jun 23 04:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience